Product Images Tabrecta
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Tabrecta NDC 0078-0716 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication description for Capmatinib HCI tablets. The tablets are equivalent to 176.55 mg. It is recommended to see the prescribing information for TABRECTA before use. The tablets should be stored between 15-30°C (59-86°F) and unused tablets should be discarded after 6 weeks. The original container with a desiccant should be used and kept out of reach of children. The medication is manufactured by Novartis Pharmaceuticals Corp in East Hanover, NJ.*
Tabrecta (capmatinib HCI) is a film-coated tablet that comes in a container with desiccant to protect it from moisture. The recommended dosage should be determined by referencing the prescribing information. Tabrecta should be stored in its original container and kept out of the reach of children. Unused tablets should be discarded six weeks after opening. *
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.